scholarly article | Q13442814 |
P356 | DOI | 10.1038/NPROT.2006.29 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/nprot.2006.29 |
P698 | PubMed publication ID | 17406232 |
P50 | author | Dario Neri | Q42611693 |
Christoph Roesli | Q42830919 | ||
P2093 | author name string | Jascha-N Rybak | |
P2860 | cites work | Genes expressed in human tumor endothelium | Q24290105 |
In silico cloning of novel endothelial-specific genes | Q24622418 | ||
In situ assembly of enzyme inhibitors using extended tethering | Q27640418 | ||
Improving the efficacy of antibody-based cancer therapies | Q28208361 | ||
Discovering high-affinity ligands for proteins: SAR by NMR | Q29617569 | ||
Encoded self-assembling chemical libraries | Q30760719 | ||
Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel. | Q32038879 | ||
Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model | Q32145219 | ||
Design, construction, and characterization of a large synthetic human antibody phage display library | Q33214820 | ||
Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy | Q34326254 | ||
Making antibodies by phage display technology | Q34328794 | ||
Arming antibodies: prospects and challenges for immunoconjugates | Q34449555 | ||
Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin | Q35747752 | ||
Tumour vascular targeting | Q36146905 | ||
ED-B fibronectin as a target for antibody-based cancer treatments | Q36158702 | ||
Organ targeting in vivo using phage display peptide libraries | Q36795550 | ||
Radioimmunotherapy of solid tumors by targeting extra domain B fibronectin: identification of the best-suited radioimmunoconjugate | Q40365980 | ||
Purification of biotinylated proteins on streptavidin resin: a protocol for quantitative elution | Q44993120 | ||
In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature | Q46396196 | ||
Engineered vascular-targeting antibody-interferon-γ fusion protein for cancer therapy | Q57912114 | ||
Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix | Q57912149 | ||
Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin | Q57912156 | ||
Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature | Q60542083 | ||
Monoclonal antibody therapy of cancer | Q81189032 | ||
P433 | issue | 1 | |
P304 | page(s) | 192-199 | |
P577 | publication date | 2006-06-01 | |
P1433 | published in | Nature Protocols | Q3337109 |
P1476 | title | In vivo protein biotinylation and sample preparation for the proteomic identification of organ- and disease-specific antigens accessible from the vasculature | |
P478 | volume | 1 |
Q28546580 | A mass spectrometric-derived cell surface protein atlas |
Q37257654 | Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions. |
Q45869295 | An atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemia. |
Q41835329 | Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells |
Q35108536 | Differential axial localization along the mouse brain vascular tree of luminal sodium-dependent glutamine transporters Snat1 and Snat3 |
Q34141688 | Direct detection of biotinylated proteins by mass spectrometry |
Q33309341 | Identification of accessible human cancer biomarkers using ex vivo chemical proteomic strategies |
Q33657479 | Ionizing radiation reduces ADAM10 expression in brain microvascular endothelial cells undergoing stress-induced senescence |
Q36677212 | Ligand-based vascular targeting of disease |
Q37633129 | Ligand-directed cancer gene therapy to angiogenic vasculature |
Q43098793 | Protein biotinylation |
Q57912000 | Proteomic identification of vanin-1 as a marker of kidney damage in a rat model of type 1 diabetic nephropathy |
Q30570718 | Proteomic profiling of cardiac tissue by isolation of nuclei tagged in specific cell types (INTACT) |
Q30580276 | Quantity and accessibility for specific targeting of receptors in tumours |
Q35949683 | Surface-exposed proteins of Ehrlichia chaffeensis |
Q37036085 | The Cardiac TBX5 Interactome Reveals a Chromatin Remodeling Network Essential for Cardiac Septation |
Q36432402 | The proteomics big challenge for biomarkers and new drug-targets discovery |
Search more.